Ovarian Cancer: Enhancing Treatment with Targets and Companion Diagnostics

Ovarian Cancer: Enhancing Treatment with Targets and Companion Diagnostics consists of a single presentation with discussion featuring Drs. Bradley J. Monk, MD and Robert L. Coleman, MD.At the conclusion of ...

Ovarian Cancer: Enhancing Treatment with Targets and Companion Diagnostics consists of a single presentation with discussion featuring Drs. Bradley J. Monk, MD and Robert L. Coleman, MD.At the conclusion of Ovarian Cancer: Enhancing Treatment with Targets and Companion Diagnostics, you will be able to: • Appraise the pathophysiology of ovarian cancer and their associated mutations, including germline and somatic BRCA mutations and other DNA repair deficiencies such as loss of heterozygosity • Evaluate the safety and efficacy data of PARP inhibitors • Use the latest diagnostic tools and genetic testing to identify patients who would benefit from PARP inhibitor therapyTarget Audience: This program is intended for Medical and gynecologic oncologists, oncology nurses, nurse practitioners, pharmacists, and other health care professionals, including gynecologists, primary care physicians, physicians-in-training, and physician assistants involved in and/or interested in the management of patients with ovarian cancer.

---

Write the first review

Resource tags